Health and Healthcare

All Health and Healthcare Articles

Newest first · Page 366

Trimeris Gives Up On Biojector (TRMS, BJCT)

Trimeris Inc. (NASDAQ:TRMS) is feeling a little after-hour pressure.  Roche and Trimeris today provided an update on their combined efforts to offer a needle-free device which has been investigated for use with FUZEON® (enfuvirtide).…

Douglas A. McIntyre · 19 years ago

Metabasis Escapes Biotech Zombiedom (MBRX)

Metabasis Therapeutics (NASDAQ:MBRX) announced after the close today that its MB07133 has been granted orphan medicinal product status for the treatment of hepatocellular carcinoma (primary liver cancer) by the European Commission. This designation would…

Douglas A. McIntyre · 19 years ago

Pfizer (PFE): Love Thy Neighbor, Until He Sues You

The Nigerian government is suing Pfizer (PFE) claiming that it "deceived patients and caused the death of 11 children in 1996 when it performed clinical trials for a new drug." According to the government,…

Douglas A. McIntyre · 19 years ago

Pfizer (PFE) Not Up On Viagra

A Canadian court ruled that Apotex could not market a generic version of Viagra, Pfizer’s (PFE) massively successful ED drug. Oddly, Pfizer’s shares were down 1.2% to $24.35. The Big Pharma company has watched…

Douglas A. McIntyre · 19 years ago

SIGA Rocks On Its Small Pox Candidate (SIGA)

SIGA Technologies, Inc. (NASDAQ: SIGA) shares are trading higher after the company announced that its lead smallpox drug, ST-246, has passed another milestone by demonstrating 100% protection against death in cynomolgus monkeys showing signs…

Douglas A. McIntyre · 19 years ago

Cephalon’s FDA Warning More of a Formality (CEPH)

Cephalon Inc. (NASDAQ:CEPH) is a biotech that has been under a bit of a low ceiling after its recent blunder regarding FENTORA.  As a reminder FENTORA is that cancer pain drug that the company…

Douglas A. McIntyre · 19 years ago

Sonus (SNUS) Gets Slaughtered

Sonus Pharmaceuticals (SNUS) said that its drug candidate Tocosol Paclitaxel failed in a late-stage study aimed at treating breast cancer, according to AP. The company was trashed by investors, who moved it down 85%…

Douglas A. McIntyre · 19 years ago

IPO FILING: EMPHASYS MEDICAL, INC. (EMPH)

EMPHASYS MEDICAL, INC. has filed to come public via an initial public offering and has listed it initial sale of securities as up to $86.25 million for filing purposes.  The underwriting group includes Morgan…

Douglas A. McIntyre · 19 years ago

BioCryst Botched Flu Results (BCRX)

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has announced preliminary findings from a Phase II study with intramuscular injection of Peramivir, the Company’s product candidate for the treatment of seasonal and life-threatening influenza. It states that…

Douglas A. McIntyre · 19 years ago

IPO Filing: MAKO Surgical Corp.

MAKO Surgical Corp. has filed to come public in an initial public offering and for nominal filing purposes, it lists that it will sell up to $86.25 million in securities.  MAKO is taking the…

Douglas A. McIntyre · 19 years ago

Food Makers Ask FDA For More Regulation: Target China

The Grocery Manufacturers Association is going to ask the government to strengthen regulation of food imports. The group, which includes Kraft (KFT) and Coca-Cola (KO) wants "beef up federal oversight of imported food and…

Douglas A. McIntyre · 19 years ago

More Tainted Products From China, Drugs This Time

The Chinese are now poisoning their own population. With any luck, a new case of tainted drugs found in the big Asian country will not make it to the US. But, don’t count on…

Douglas A. McIntyre · 19 years ago

ISIS Scores On J&J Collaboration & Milestones (ISIS, JNJ)

ISIS Pharmaceuticals Inc. (NASDAQ:ISIS) is trading up pre-market on new that it entered a broad collaboration with Ortho-McNeil, a Johnson & Johnson (NYSE:JNJ) unit, for discovery, development and commercialization of antisense drugs to treat…

Douglas A. McIntyre · 19 years ago

Cardica Trumps Wall St.

Shares in Cardica (CRDC) fell of a cliff yesterday as an A.G. Edwards analyst downgraded the stock on muted enthusiasm for its new surgical product. The fellow must feel a bit embarrassed today. CRDC…

Douglas A. McIntyre · 19 years ago

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels in kidney-failure patients being…

Douglas A. McIntyre · 19 years ago